Hepatocellular Carcinoma and Transarterial Chemo-Embolization

The most well-known kind of adult essential liver growth and the most common cause of death in cirrhotic people is hepatocellular carcinoma (HCC). It occurs when the liver is constantly becoming worse and is most strongly linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins like alcohol or aflatoxin. Alpha 1-antitrypsin deficiency and hemochromatosis are two conditions that increase the risk of treating HCC. Similar to other malignancies, HCC therapy and prognosis depend on the characteristics of the, tumor's histology measurement, extent of growth, and overall health.

 

    Related Conference of Hepatocellular Carcinoma and Transarterial Chemo-Embolization

    June 04-05, 2025

    25th International Conference on Gastroenterology and Hepatology

    Edinburgh, Scotland
    July 07-08, 2025

    20th Euro-Global Gastroenterology Conference

    Zurich, Switzerland
    July 28-29, 2025

    31st World Conference on Gastroenterology & Hepatology

    Dubai, UAE
    July 30-31, 2025

    16th International Conference on Liver Diseases & Hepatology

    Aix-en-Provence, France
    July 30-31, 2025

    4th International Conference on Gastroenterology and Liver

    Paris, France
    August 21-22, 2025

    6th Global Summit on Earth Science and Climate Change

    Paris, France
    August 21-22, 2025

    17th World Conference on Gynecology, Obstetrics and Women Health

    London, UK
    August 27-28, 2025

    13th World Gastro Summit

    Paris, France
    September 29-30, 2025

    7th International Conference on Gastroenterology and Liver Diseases

    Paris, France
    October 20-21, 2025

    24th International Conference on Gastroenterology and Digestive Disorders

    Osaka, Japan

    Hepatocellular Carcinoma and Transarterial Chemo-Embolization Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in